Anti-CD20 Antibody and Calcineurin Inhibitor Combination Therapy Effectively Suppresses Antibody-Mediated Rejection in Murine Orthotopic Lung Transplantation

Antibody-mediated rejection (AMR) is a risk factor for chronic lung allograft dysfunction, which impedes long-term survival after lung transplantation. There are no reports evaluating the efficacy of the single use of anti-CD20 antibodies (aCD20s) in addition to calcineurin inhibitors in preventing...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Hiroki, Suzuki, Hidemi, Yamanaka, Takahiro, Kaiho, Taisuke, Hata, Atsushi, Inage, Terunaga, Ito, Takamasa, Kamata, Toshiko, Tanaka, Kazuhisa, Sakairi, Yuichi, Motohashi, Shinichiro, Yoshino, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608275/
https://www.ncbi.nlm.nih.gov/pubmed/37895424
http://dx.doi.org/10.3390/life13102042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608275/
https://www.ncbi.nlm.nih.gov/pubmed/37895424
http://dx.doi.org/10.3390/life13102042

Ejemplares similares